DBD DIEBOLD NIXDORF, Inc
Calculating & Accounting Machines (No Electronic Computers) · NYSE · SEC CIK 28823 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY6.3%
TTM net income YoY51.6%
TTM EPS YoY56.3%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin25.0%
Operating margin5.4%
Net margin2.0%
FCF margin—
EBITDA margin7.3%
Returns
ROE7.5%
ROA2.1%
ROIC (approx.)8.1%
Asset turnover1.06x
Leverage & solvency
Liabilities / assets74.2%
Debt / equity1.01x
Current ratio1.27x
Interest coverage2.23x
Cash quality & payout
Operating cash flow / net income2.45x
Accruals ratio-3.0%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $994.30M | $930.80M | $891.80M | $1.10B | $945.20M | $915.20M | $841.10M | $988.90M |
| Cost of revenue | $747.10M | $691.20M | $678.70M | $824.40M | $700.10M | $681.20M | $638.70M | $757.30M |
| Gross profit | $247.20M | $239.60M | $213.10M | $279.80M | $245.10M | $234.00M | $202.40M | $231.60M |
| R&D expense | $19.80M | $20.50M | $22.10M | $21.40M | $20.30M | $22.40M | $22.70M | $23.90M |
| SG&A expense | $172.20M | $162.30M | $157.20M | $175.60M | $150.90M | $154.20M | $151.80M | $165.20M |
| Operating income | $38.80M | $57.40M | $32.70M | $82.40M | $73.80M | $56.20M | $29.60M | $41.20M |
| Interest expense | $26.70M | $24.10M | $23.30M | $20.60M | $21.80M | $21.80M | $21.50M | $34.70M |
| Pretax income | $15.30M | $36.30M | $12.40M | $62.80M | $52.40M | $17.20M | -$7.40M | $6.50M |
| Income tax | $5.60M | $19.20M | $5.70M | $11.90M | $9.60M | $4.80M | -$2.20M | $5.50M |
| Net income | $6.60M | $15.50M | $5.00M | $49.60M | $41.10M | $12.20M | -$8.30M | $5.60M |
| EBITDA | $45.50M | $63.30M | $64.10M | $113.10M | $82.40M | $65.40M | $63.50M | $79.40M |
| EPS (basic) | 0.20 | 0.45 | 0.14 | — | 1.13 | 0.33 | -0.22 | — |
| EPS (diluted) | 0.19 | 0.44 | 0.14 | — | 1.11 | 0.33 | -0.22 | — |
| Weighted avg. shares (diluted) | 34.60M | 35.30M | 35.70M | — | 37.00M | 37.50M | 37.60M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $184.90M | $282.40M | $358.60M | $387.30M | $262.60M | $295.20M | $320.20M | $311.30M |
| Short-term investments | $0 | $0 | $0 | $29.10M | $17.40M | $15.20M | $8.10M | $16.90M |
| Receivables | $577.40M | $573.40M | $597.00M | $609.40M | $580.10M | $599.40M | $602.60M | $588.50M |
| Inventory | $561.70M | $595.90M | $553.10M | $521.00M | $599.70M | $574.00M | $553.00M | $528.10M |
| Current assets | $1.66B | $1.71B | $1.80B | $1.79B | $1.72B | $1.74B | $1.73B | $1.67B |
| PP&E, net | — | — | — | — | — | — | $130.70M | $128.10M |
| Goodwill | $626.20M | $627.80M | $632.10M | $642.40M | $642.10M | $641.20M | $603.90M | $586.40M |
| Intangibles | $725.80M | $743.20M | $764.60M | $792.40M | $808.10M | $815.70M | $784.00M | $778.60M |
| Total assets | $3.66B | $3.74B | $3.83B | $3.85B | $3.72B | $3.74B | $3.63B | $3.54B |
| Current liabilities | $1.30B | $1.35B | $1.40B | $1.37B | $1.26B | $1.27B | $1.28B | $1.27B |
| Short-term debt | — | — | — | — | — | — | $300,000 | $200,000 |
| Long-term debt | $949.30M | $942.90M | $939.40M | $938.50M | $934.00M | $931.10M | $928.70M | $927.30M |
| Total debt | $949.30M | $942.90M | $939.40M | $938.50M | $934.00M | $931.10M | $929.00M | $927.50M |
| Total liabilities | $2.72B | $2.76B | $2.80B | $2.75B | $2.61B | $2.63B | $2.63B | $2.61B |
| Shareholders' equity | $936.20M | $969.20M | $1.02B | $1.10B | $1.11B | $1.10B | $984.00M | $929.80M |
| Net debt | $764.40M | $660.50M | $580.80M | $551.20M | $671.40M | $635.90M | $608.80M | $616.20M |
| Shares outstanding | 33.59M | 34.00M | 34.75M | 35.38M | 36.20M | 36.86M | 37.46M | 37.58M |
| Cash flow statement | ||||||||
| Operating cash flow | -$47.40M | -$13.60M | $31.70M | $217.50M | $37.40M | $30.10M | $15.70M | $196.20M |
| Investing cash flow | -$13.20M | -$15.50M | $20.20M | -$38.60M | -$26.20M | -$32.80M | $0 | -$17.30M |
| Financing cash flow | -$36.00M | -$62.50M | -$62.20M | -$55.70M | -$44.10M | -$31.30M | -$12.80M | -$192.00M |
| Depreciation & amortization | $6.70M | $5.90M | $31.40M | $30.70M | $8.60M | $9.20M | $33.90M | $38.20M |
| Stock-based compensation | $4.30M | $4.20M | $3.20M | $2.80M | $3.00M | $3.30M | $3.00M | $2.30M |
| Share buybacks | $33.90M | $60.60M | $60.40M | $51.10M | $39.90M | $30.10M | $9.60M | $0 |
Free plan shows the latest 8 periods; Pro shows all 68 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.